RNA-dependent RNA polymerase

It is rare to find a mention of Giliead's remdesivir, arguably the most promising drug in the fight against coronavirus, without also hearing that it failed miserably in fighting Ebola.
There is now a potentially important change in the pharmaceutical landscape of anti-coronavirus drugs.